邱立华, 姜之馨, 魏熙胤, 牛瑞芳, 王慧君, 佟仲生, 李凯, 王华庆. 非霍奇金淋巴瘤骨髓受累的免疫表型探讨[J]. 中国肿瘤临床, 2006, 33(7): 391-394.
引用本文: 邱立华, 姜之馨, 魏熙胤, 牛瑞芳, 王慧君, 佟仲生, 李凯, 王华庆. 非霍奇金淋巴瘤骨髓受累的免疫表型探讨[J]. 中国肿瘤临床, 2006, 33(7): 391-394.
Qiu Li-hua, Jiang Zhi-xin, Wei Xi-yin, . The Immunophenotypic Character of Non-Hodgkin's Lymphoma with Bone Marrow Involvement[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 33(7): 391-394.
Citation: Qiu Li-hua, Jiang Zhi-xin, Wei Xi-yin, . The Immunophenotypic Character of Non-Hodgkin's Lymphoma with Bone Marrow Involvement[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 33(7): 391-394.

非霍奇金淋巴瘤骨髓受累的免疫表型探讨

The Immunophenotypic Character of Non-Hodgkin's Lymphoma with Bone Marrow Involvement

  • 摘要: 目的:探讨非霍奇金淋巴瘤(NHL)骨髓受累的免疫表型特点。方法:应用流式细胞术对NHL患者的骨髓标本进行检测,收集受累者的CD分子表达数据。结果:1)在46例受检者中,31例阳性,阳性率67.39%,(95%可信区间53.84%,80.94%)。经骨髓形态学检查确证为骨髓受累。2)31例阳性者中,B细胞NHL23例,T细胞NHL7例,NK细胞NHL1例。B细胞NHL标记抗原出现频率最高的为CD19,CD20;T细胞NHL标记抗原出现频率最高的为CD7。6例B细胞淋巴瘤同时表达T细胞抗原,1例B细胞淋巴瘤还表达髓系抗原标志。结论:1)NHL骨髓受累免疫表型特点为B细胞来源:CD19、CD20;T细胞来源:CD7。2)T、B细胞抗原同时表达不少见。3)可同时表达髓系抗原。

     

    Abstract: Objective: To analyze the immunophenotypic character of non-Hodgkin's lymphoma(NHL) with bone marrow involvement. Methods: Bone marrow of NHL patients was detected by flow cytometry, expression of CD antigen was collected at the same time. Results: 1) Among 46 NHL pa-tients, 31 were found to suffer the bone marrow involvement. 2) Of the 31 cases, 23 were B-cell lym-phoma, 7 were T-cell lymphoma and 1 was NK-cell lymphoma. 3) The highest frequency antigenm arkers of the B-cell NHL were CD19 and CD20, and T-cell NHL was CD7. However, 6 cases with B-cell lymphoma expressed T cells marker and 1 with B-cell lymphoma expressed the T-cells and the myeloid lineage marker both. Conclusion: 1) The antigen markers of B-cell NHL with bone marrow in-volvement are CD19 and CD20, and T-cell NHL is CD7. 2) NHL patients often express T-and B-cellmaker both. 3 ) NHL can also expresses myeloid lineage marker.

     

/

返回文章
返回